News room

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Media contact

 

Karl Hård, VP Investor Relations & Business Development

[email protected]

Calendar and upcoming reports

August 21, 2025
Interim Report Q2 2025 (7:00am CEST)

November 7, 2025
Interim Report Q3 2025 (7:00am CET)

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: [email protected]